Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junping Shi

Showing results (161-170 of 178) with videos related to

Pageof 18
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 24, 2017
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis BRui Yu, Deming Tan, Qin Ning, et al.
Eclinicalmedicine|January 31, 2024
Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort studyFajuan Rui, Yee Hui Yeo, Liang Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 21, 2024
Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic SteatosisFajuan Rui, Liang Xu, Yee Hui Yeo, et al.
Journal of Gastroenterology and Hepatology|October 30, 2014
Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patientsXieer Liang, Jun Cheng, Yongtao Sun, et al.
Chinese Medical Journal|February 27, 2023
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry studyHuai Zhang, Rafael S Rios, Jerome Boursier, et al.
Hepatology (Baltimore, Md.)|July 28, 2025
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled studyYameng Sun, Cuisong Wu, Guijie Xin, et al.
JHEP Reports : Innovation in Hepatology|December 13, 2023
Fine mapping identifies independent HLA associations in autoimmune hepatitis type 1You Li, Lu Zhou, Zuxiong Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2024
Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular CarcinomaCunjie Chang, Lina Li, Ling Su, et al.
Science Translational Medicine|November 6, 2024
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese populationJingjing Ding, Huaizheng Liu, Xiaoxun Zhang, et al.
Nature Communications|March 17, 2022
The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinomaCunjie Chang, Muthukumar Rajasekaran, Yiting Qiao, et al.
Pageof 18

Showing results (161-170 of 178) with videos related to

Sort By:
Pageof 18
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 24, 2017
Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis BRui Yu, Deming Tan, Qin Ning, et al.
Eclinicalmedicine|January 31, 2024
Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort studyFajuan Rui, Yee Hui Yeo, Liang Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 21, 2024
Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic SteatosisFajuan Rui, Liang Xu, Yee Hui Yeo, et al.
Journal of Gastroenterology and Hepatology|October 30, 2014
Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patientsXieer Liang, Jun Cheng, Yongtao Sun, et al.
Chinese Medical Journal|February 27, 2023
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry studyHuai Zhang, Rafael S Rios, Jerome Boursier, et al.
Hepatology (Baltimore, Md.)|July 28, 2025
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled studyYameng Sun, Cuisong Wu, Guijie Xin, et al.
JHEP Reports : Innovation in Hepatology|December 13, 2023
Fine mapping identifies independent HLA associations in autoimmune hepatitis type 1You Li, Lu Zhou, Zuxiong Huang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2024
Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular CarcinomaCunjie Chang, Lina Li, Ling Su, et al.
Science Translational Medicine|November 6, 2024
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese populationJingjing Ding, Huaizheng Liu, Xiaoxun Zhang, et al.
Nature Communications|March 17, 2022
The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinomaCunjie Chang, Muthukumar Rajasekaran, Yiting Qiao, et al.
Pageof 18